Option Care Health Announces $5.8 Billion Acquisition by McKesson and CD&R
Shares of Option Care Health (NASDAQ: OPCH) surged over 32% following the announcement that it has agreed to be acquired in a $5.8 billion deal led by McKesson Corporation and private equity firm Clayton, Dubilier & Rice (CD&R). The acquisition price is set at $32.05 per share, representing a premium of approximately 37% over Option Care's closing price on Monday. The transaction will see CD&R own 51% of the combined entity while McKesson retains 49%, with an option for McKesson to acquire CD&R’s stake in the future under certain conditions. The deal is expected to close by mid-2027, pending shareholder and regulatory approvals. Despite a recent decline due to weak Q1 results, Option Care's stock remains below its earlier peak of this year. McKesson CEO Brian Tyler stated that the acquisition aligns with their strategic goals in expanding access to high-quality care through alternate infusion therapies.
Topics: acquisitions healthcare infusion services private equity